No 04 2018

Researchers at the University of Gothenburg have developed a treatment for acute myeloid leukemia that forces cancer cells to run at full throttle while cutting off their energy supply, driving them to burn out and die from the stress. The first study in mice shows highly promising results.

Klaria has entered a collaboration agreement with RTHS to combine RTHS's sensor-based measurements of blood flow dynamics with Klaria's approved migraine treatment, aiming to detect migraine attacks before symptoms set in.

When people think of life science innovation, they often think of new medicines. Yet many of the innovations transforming healthcare today – from AI-powered diagnostics to robotic surgery and remote patient monitoring – are driven by medtech companies. With my own multiyear background in the medtech industry, this section of life science has a special place in my heart.

A post-hoc analysis of SynAct Pharma's Phase 2b ADVANCE study confirms earlier positive results for resomelagon in rheumatoid arthritis (RA), and the company now plans to discuss Phase 3 trial design with the FDA in Q4 2026.

Ada Yonath, the 2009 Nobel laureate in Chemistry, died on August 31, 2026, at the age of 87. She was one of the first Nobel Prize laureates I interviewed as a new editor at Nordic Life Science – and the first I met in person, over an interview at the Grand Hotel in Stockholm. Yonath, who in 2009 became the first woman in 45 years to win the Nobel Prize in Chemistry, spoke to me about her curiosity, polar bears, extremely durable bacteria from the Black Sea, and her passion for science.

Neola Medical has been granted Breakthrough Device Designation by the US FDA for Neola, its non-invasive lung monitor for preterm babies, designed to give early warning of life-threatening lung collapse.

Bioretec has received FDA 510(k) clearance for ActivaScrew Cannulated COM, a new bioabsorbable compression screw that expands its Activa implant portfolio into the US market.